Skip to main content
. 2021 Apr 2;10(3):2102. doi: 10.4081/jphr.2021.2102

Table 2.

Association between demographic characteristics, clinical history, exposure information and COVID-19 IgG seroprevalence (n=455).

Demographic characteristics IgG p
+VE n=36 -VE n=419
Age (mean ± SD) 33.4 ± 9.3 32.8 ± 8.2 0.707
Gender (n, %)
    Male 16 (44.4%) 223 (53.2%) 0.312
Clinical history (n, %)
    Past surgical history (n, %) 12 (33.3%) 106 (25.3%) 0.291
    Past medical history (n, %) 8 (22.2%) 81 (19.3%) 0.675
    Hypertension 2 (5.6%) 23 (5.5%) 1.000
    Diabetes 0 (0) 9 (2.1%) 1.000
    Asthma 1 (2.8%) 18 (4.3%) 1.000
    Allergy 1 (2.8%) 15 (3.6%) 1.000
    Other medical conditions# 3 (8.3%) 22 (5.3%) 0.436
    Medication intake (n, %) 9 (25%) 90 (21.5%) 0.623
Smoking history (n, %)
    Current smoker 2 (5.6%) 22 (5.3%) 1.000
    Ex-smoker 6 (16.7%) 56 (13.4%) 0.611
    Non-smoker 28 (77.8%) 341 (81.4%) 0.596
Symptoms in the past 2 weeks (n, %)
    Flu-like illness 8 (22.2%) 100 (23.9%) 0.824
    Wheezing 6 (16.7%) 36 (8.6%) 0.127
    Fever 5 (13.9%) 56 (13.4%) 1.000
    Gastroenteritis 8 (22.2%) 88 (21%) 0.863
    Sore throat 9 (25%) 124 (29.6%) 0.561
    Muscle aches 10 (27.8%) 71 (16.9%) 0.103

#Liver disease, renal disease, cancers, and autoimmune and other immunological disorders.